Gene · 3598
Papers2,877
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
901 to 920 of 2,877
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Hyperactive neutrophil chemotaxis contributes to anti-tumor necrosis factor-α treatment resistance in inflammatory bowel disease. | J Gastroenterol Hepatol | 2022 | 34931384 | PubTator, text mining | PubMed |
| Chitinase 3-like 1 secreted from cancer-associated fibroblasts promotes tumor angiogenesis via interleukin-8 secretion in colorectal cancer. | Int J Oncol | 2022 | 34913066 | PubTator, text mining | PubMed |
| Circular RNAs in stem cells: from basic research to clinical implications. | Biosci Rep | 2022 | 34908111 | PubTator, text mining | PubMed |
| 3D-printed dermis-specific extracellular matrix mitigates scar contraction via inducing early angiogenesis and macrophage M2 polarization. | Bioact Mater | 2022 | 34901542 | PubTator, text mining | PubMed |
| Randomized trial of neoadjuvant vaccination with tumor-cell lysate induces T cell response in low-grade gliomas. | J Clin Invest | 2022 | 34882581 | PubTator, text mining | PubMed |
| In situ analysis of variations of arsenicals, microbiome and transcriptome profiles along murine intestinal tract. | J Hazard Mater | 2022 | 34876320 | PubTator, text mining | PubMed |
| Anti-Chi3L1 antibody suppresses lung tumor growth and metastasis through inhibition of M2 polarization. | Mol Oncol | 2022 | 34861103 | PubTator, text mining | PubMed |
| Using chimeric antigen receptor T-cell therapy to fight glioblastoma multiforme: past, present and future developments. | J Neurooncol | 2022 | 34825292 | PubTator, text mining | PubMed |
| Neurosurgery at the crossroads of immunology and nanotechnology. New reality in the COVID-19 pandemic. | Adv Drug Deliv Rev | 2022 | 34808227 | PubTator, text mining | PubMed |
| A small molecule targeting CHI3L1 inhibits lung metastasis by blocking IL-13Rα2-mediated JNK-AP-1 signals. | Mol Oncol | 2022 | 34758182 | PubTator, text mining | PubMed |
| Transcriptome Analysis Reveals Intrinsic Proinflammatory Signaling in Healthy African American Skin. | J Invest Dermatol | 2022 | 34757068 | PubTator, text mining | PubMed |
| Limb-bud and heart development (LBH) contributes to glioma progression in vitro and in vivo. | FEBS Open Bio | 2022 | 34739189 | PubTator, text mining | PubMed |
| Gut microbiome, Vitamin D, ACE2 interactions are critical factors in immune-senescence and inflammaging: key for vaccine response and severity of COVID-19 infection. | Inflamm Res | 2022 | 34738147 | PubTator, text mining | PubMed |
| Glioma: molecular signature and crossroads with tumor microenvironment. | Cancer Metastasis Rev | 2022 | 34687436 | PubTator, text mining | PubMed |
| New Approaches to Glioblastoma. | Annu Rev Med | 2022 | 34665646 | PubTator, text mining | PubMed |
| Comprehensive phenotyping of human peripheral blood B lymphocytes in healthy conditions. | Cytometry A | 2022 | 34664397 | PubTator, text mining | PubMed |
| Molecular imaging of cellular immunotherapies in experimental and therapeutic settings. | Cancer Immunol Immunother | 2022 | 34657195 | PubTator, text mining | PubMed |
| Characterization of the Genomic and Immunologic Diversity of Malignant Brain Tumors through Multisector Analysis. | Cancer Discov | 2022 | 34610950 | PubTator, text mining | PubMed |
| Endothelial cell-derived pro-fibrotic factors increase TGF-β1 expression by smooth muscle cells in response to cycles of hypoxia-hyperoxia. | Biochim Biophys Acta Mol Basis Dis | 2022 | 34601016 | PubTator, text mining | PubMed |
| Synthetic receptors for logic gated T cell recognition and function. | Curr Opin Immunol | 2022 | 34571290 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3598/papers?page=46